Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

NCT06913998 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06913998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06913998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 27, 2023
Completion date
November 30, 2026
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, neutropenia, nudt15 deficiency